期刊文献+

miR-126在宫颈癌组织中的表达及其临床意义 被引量:3

Expression of miR-126 in cervical cancer and its clinical significance
下载PDF
导出
摘要 目的研究mi R-126在宫颈癌组织中的表达并探讨其临床意义。方法收集宫颈癌组织标本78例。采用q RT-PCR技术检测宫颈癌组织及癌旁正常宫颈组织中mi R-126的表达情况,并分析mi R-126在宫颈癌组织中的表达水平与宫颈癌患者临床病理参数之间的关系。结果 mi R-126在宫颈癌组织中的表达相对于癌旁正常宫颈组织中的表达明显下调(P〈0.001)。mi R-126在宫颈癌组织中的高表达率与宫颈癌患者的组织分化程度、淋巴结转移以及临床分期明显相关,即mi R-126在低分化组的高表达率明显低于高中分化组(P=0.013),在有淋巴结转移组的高表达率明显低于无淋巴结转移组(P=0.005),在Ⅲ~Ⅳ期组中的高表达率明显低于Ⅰ~Ⅱ期(P=0.007)。而mi R-126在宫颈癌组织中的高表达率在不同年龄、肿瘤大小、HPV感染患者组之间比较差异均无统计学意义(P〉0.05)。结论 mi R-126可能参与宫颈癌的发生发展,检测mi R-126的在宫颈癌中的表达对预测宫颈癌的浸润转移具有重要意义。 Objective To investigate the expression of miR-126 in cervical cancer and its clinical signifi-cance. Methods Expression of miR-126 was detected in 78 cases of cervical cancer by qRT-PCR. The correlations of miR-126 expression with clinicopathologic characteristics of cervical cancer patients were analyzed. Results The expression of miR-126 were significantly down-regulated in cervical cancer tissues than in the adjacent normal tis-sues. The difference was statistically significant (P〈0.001). Decreased miR-126 expression in cervical cancer was found to be significantly associated with histological grade (P=0.013), lymph node metastasis (P=0.005), and the FI-GO stage (P=0.007). However, there was no statistically significant difference between the expression and age, tumor size, as well as HPV infection (P〉0.05). Conclusion The expression of miR-126 may be involved in the occurrence and development of cervical cancer. Detection of miR-126 expression in cervical cancer is of great importance in the prediction of invasion and metastasis.
出处 《海南医学》 CAS 2015年第17期2513-2515,共3页 Hainan Medical Journal
基金 湖南省中医药科研计划项目(编号:201139)
关键词 MIR-126 宫颈癌 侵袭 转移 MiR-126 Cervical cancer Invasion Metastasis
  • 相关文献

参考文献13

  • 1Tang H, Deng M, Tang Y, et al. miR-200b and miR-200c as prog- nostic factors and mediators of gastric cancer cell progression [J]. Clin Cancer Res, 2013, 19(20): 5602-5612.
  • 2Walter BA, Valera VA, pinto PA, et al. Comprehensive microRNA profiting of prostate cancer [I]. ] Cancer Educ, 2013,4(5): 350-357.
  • 3Wang X, Tang S, Le SY, et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancerceU growth [J]. PLoS One, 2008, 3(7): e2557.
  • 4Tavazoie SF, Alareon C, Oskarsson T, et al. Endogenous human mi- eroRNAs that suppress breast cancer metastasis [J]. Nature, 2008, 451(7175): 147-152.
  • 5Liu Y, Zhou Y, Fcng X, et al. Low expression of microRNA-126 is associated with Ixor prognosis in colorectal cancer [J]. Genes Chro- mosom Cancer, 2014, 53(4): 358-365.
  • 6Ishihara K, Sasaki D, Tsuruda K, ct al. Impact ot mlK-13 and miR-126 as novel biomarkers on the assessment of disease progres- sion and prognosis in adult T-cell leukemia [J]. Cancer Epidemiol, 2012, 36(6): 560-565.
  • 7Tomasetti M, Staffolani S, Nocchi L, et al. Clinical significance of circulating miR-126 quantification in malignant mesothelioma pa- tients [J]. Clin Biochem, 2012, 45(7-8): 575-581.
  • 8Tang H, Kong Y, Guo J, et al. Diallyl disulfide suppresses prolifera- tion and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regnlation of miR-200b and miR-22 [Y]. Cancer Lett, 2013, 340(1): 72-81.
  • 9唐云云,唐海林,苏琦.microRNA在胃癌中的生物学作用[J].中国肿瘤临床,2014,41(2):131-133. 被引量:10
  • 10Zhu N, Zhaug D, Xie H, et al. Endothelial-specific in, ton-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2 [J]. Mol Cell Biochem, 2011, 351(1-2): 157-164.

二级参考文献26

  • 1Bartel DP. MicroRNAs:genomics,biogenesis,mechanism,and function[J].{H}CELL,2004,(02):281-297.
  • 2Li ZH,Pan XM,Han BW. A let-7 binding site polymor-phism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer[J].{H}TUMOUR BIOLOGY,2013,(05):3159-3163.
  • 3Xu Y,Ma H,Yu H. The miR-184 binding-site rs8126 T》C polymorphism in TNFAIP2 is associated with risk of gastric cancer[J].PLoS One,2013,(05):e64973.
  • 4Zeng XF,Li J,Li SB. A functional polymorphism in IL-1A gene is associated with a reduced risk of gastric cancer[J].{H}TUMOUR BIOLOGY,2013.
  • 5Yang Q,Jie Z,Ye S. Genetic variations in miR-27a gene de-crease mature miR-27a level and reduce gastric cancer susceptibili-ty[J].{H}ONCOGENE,2012.
  • 6Zhou F,Zhu H,Luo D. A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population[J].DNA cellBiol,2012,(07):1290-1295.
  • 7Mu YP,Su XL. Polymorphism in pre-miR-30c contributes to gas-tric cancer risk in a Chinese population[J].{H}MEDICAL ONCOLOGY,2012,(03):1723-1732.
  • 8Zhou Y,Du WD,Chen G. Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chi-nese Han population[J].{H}Journal of Cancer Research and Clinical Oncology,2012,(06):939-945.
  • 9Zheng B,Liang L,Wang C. MicroRNA-148a suppresses tu-mor cellinvasion and metastasis by downregulating ROCK1 in gas-tric cancer[J].Cin Cancer Res,2011,(24):7574-7583.
  • 10Tang H,Deng M,Tang Y. miR-200b and miR-200c as prog-nostic factors and mediators of gastric cancer cellprogression[J].{H}Clinical Cancer Research,2013,(20):5602-5612.

共引文献9

同被引文献40

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部